en
Antibiotic resistance among anaerobic bacteria is no longer considered a rare or isolated phenomenon. Over recent decades, clinically important anaerobes have acquired and disseminated resistance mechanisms affecting several key antimicrobial classes, including beta-lactams, clindamycin, metronidazole, carbapenems and tetracyclines.
Understanding how resistance develops, spreads and impacts clinical practice is increasingly important for microbiology laboratories and healthcare professionals responsible for managing anaerobic infections.
These topics were explored in detail in our recent webinar led by Dr Alida C.M. Veloo, Researcher at the Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen (UMCG), whose work has significantly advanced our understanding of antibiotic resistance in clinically relevant anaerobic bacteria, particularly within the genera Bacteroides and Prevotella.
At a glance:
- Anaerobic resistance rates continue to increase
- Horizontal gene transfer drives resistance dissemination
- Conjugative transposons facilitate gene exchange
- Metronidazole resistance is no longer exceptional
- Carbapenem resistance mechanisms are emerging
- Multidrug-resistant anaerobes are increasingly reported
Why antibiotic resistance in anaerobes matters
Anaerobic bacteria form a substantial proportion of the normal human microbiota and play important roles in both health and disease. They are particularly abundant within the gastrointestinal tract and oral cavity, where dense microbial communities create ideal conditions for genetic exchange.
Historically, many clinically significant anaerobes were reliably susceptible to commonly used antimicrobial agents. However, resistance patterns have changed considerably over time.
Among Bacteroides species, resistance to penicillin has become widespread due to beta-lactamase production. Clindamycin resistance has increased substantially, while reports of resistance to metronidazole and carbapenems (antimicrobials traditionally considered highly effective against anaerobic pathogens) have become increasingly documented.
Although resistance rates remain lower for some agents than others, the overall trend highlights the growing adaptability of anaerobic bacteria and the importance of continued surveillance.
For clinical microbiology laboratories, these developments reinforce the value of accurate species identification, susceptibility testing and ongoing monitoring of local resistance patterns.
The microbiome as a reservoir for resistance genes
One of the key themes discussed was the role of the human microbiome as a reservoir and exchange network for antimicrobial resistance genes.
Anaerobic bacteria account for more than 95% of the bacterial population within the colon. This creates an environment where large numbers of microorganisms coexist in close proximity, providing extensive opportunities for genetic interaction.
Selective pressure resulting from antibiotic exposure (whether through clinical use, community prescribing or environmental sources) encourages the persistence and dissemination of resistance determinants.
While increasing resistance rates are often associated with antimicrobial consumption, the underlying biological mechanisms are equally important. Resistance does not simply arise through spontaneous mutation; it is frequently acquired through the movement of mobile genetic elements between bacteria.
This process, known as horizontal gene transfer, has become a major driver of antimicrobial resistance evolution in anaerobic species.
Conjugative transposons and the spread of resistance
A central focus of Dr Veloo’s presentation was the role of conjugative transposons, particularly CTnDOT-like elements found within members of the order Bacteroidales.
These mobile genetic elements are remarkable because they contain not only antibiotic resistance genes but also the machinery required for their own transfer between bacterial cells.
The best-characterised example is the tetQ-containing CTnDOT element, which confers tetracycline resistance.
When bacteria carrying CTnDOT are exposed to low concentrations of tetracycline, a regulatory cascade is activated. This initiates excision of the transposon from the chromosome and enables transfer to neighbouring bacteria via conjugation.
Other mobile genetic elements present within the same bacterial cell can effectively "hitchhike" during the transfer process. As the conjugative machinery establishes a transfer channel between donor and recipient cells, additional resistance determinants may be mobilised and transferred simultaneously.
This mechanism creates opportunities for multiple resistance genes to spread together, accelerating the development of multidrug-resistant strains.
The phenomenon helps explain how resistance traits can rapidly disseminate throughout microbial communities and why exposure to a single antimicrobial agent may influence resistance to multiple drug classes.
Key resistance mechanisms in clinically relevant anaerobes
Several important resistance genes and mechanisms were discussed during the webinar.
Beta-lactam resistance
Beta-lactam resistance among anaerobes is commonly associated with beta-lactamase production.
The cfxA gene is frequently found on mobile genetic elements and encodes a beta-lactamase capable of hydrolysing beta-lactam antibiotics.
Another important gene, cepA, is commonly present in Bacteroides fragilis division I isolates and also contributes to beta-lactam resistance. Unlike cfxA, cepA is generally chromosomally encoded and not typically associated with mobile genetic elements.
The widespread distribution of these genes has contributed significantly to declining susceptibility to penicillin among anaerobic pathogens.
Carbapenem resistance
Carbapenem resistance remains relatively uncommon compared with other resistance phenotypes but is of considerable clinical concern due to the importance of carbapenems in treating severe infections.
In Bacteroides fragilis, carbapenem resistance is primarily associated with the cfiA gene, which encodes a metallo-beta-lactamase.
Interestingly, the presence of cfiA alone does not necessarily result in clinically significant resistance. Expression is often dependent on the insertion of specific insertion sequence (IS) elements upstream of the gene, which can dramatically increase transcription and enzyme production.
This highlights an important principle in antimicrobial resistance: the presence of a resistance gene does not always predict phenotypic resistance. Regulatory mechanisms can be equally important in determining clinical susceptibility.
Additional metallo-beta-lactamase genes, including ccrA, have also been identified in species such as Bacteroides xylanisolvens, suggesting that carbapenem resistance mechanisms may be more diverse than previously appreciated.
Metronidazole resistance
Metronidazole has long been regarded as a cornerstone therapy for anaerobic infections. However, resistance is increasingly being reported in clinically relevant species.
The most recognised mechanism involves the nim family of genes, which encode 5-nitroimidazole reductases.
These enzymes reduce the activation of metronidazole and diminish the formation of toxic intermediates responsible for bacterial killing.
As with cfiA-mediated resistance, expression of nim genes may depend on the presence of insertion sequence elements that enhance transcription.
Although metronidazole resistance remains relatively uncommon, its emergence challenges longstanding assumptions regarding universal susceptibility among anaerobic bacteria and highlights the need for continued vigilance.
Clindamycin and tetracycline resistance
Resistance to clindamycin is commonly associated with ermF, while tetracycline resistance is frequently mediated by tetQ.
Both genes are often linked to mobile genetic elements, creating opportunities for dissemination through horizontal gene transfer.
Importantly, resistance genes conferring resistance to multiple antimicrobial classes may coexist within the same bacterial strain, increasing the likelihood of multidrug resistance.
Emerging evidence of multidrug-resistant anaerobes
One of the most significant concerns highlighted during the presentation was the increasing identification of multidrug-resistant anaerobic isolates.
Examples from The Netherlands demonstrated isolates resistant to both metronidazole and meropenem. These strains originated from different patients, clinical sites and geographical locations, suggesting that multidrug resistance is not restricted to a single outbreak or epidemiological cluster.
Genomic analysis revealed the presence of multiple resistance determinants, often carried on mobile genetic elements capable of transfer between bacteria.
These findings illustrate the cumulative impact of resistance acquisition mechanisms operating over time.
Rather than individual resistance genes emerging independently, bacteria may acquire packages of resistance determinants through successive transfer events, creating strains with increasingly complex resistance profiles.
Diagnostic and laboratory implications
The growing diversity of resistance mechanisms has important implications for diagnostic laboratories.
Advances in technologies such as MALDI-TOF mass spectrometry and whole genome sequencing have significantly improved the ability to identify anaerobic bacteria and characterise resistance determinants.
Dr Veloo discussed how MALDI-TOF can assist in differentiating cfiA-positive and cfiA-negative Bacteroides fragilis isolates through characteristic spectral differences.
However, genomic methods remain essential for understanding whether resistance genes are actively expressed and for identifying the mobile genetic elements responsible for their dissemination.
As resistance mechanisms become increasingly complex, combining phenotypic susceptibility testing with molecular and genomic approaches may become increasingly valuable for comprehensive resistance surveillance.
Looking ahead: understanding resistance ecology
A particularly thought-provoking aspect of the discussion centred on the ecological consequences of resistance gene exchange within the gut microbiome.
Given the abundance of Bacteroidetes within the human gastrointestinal tract and the prevalence of mobile genetic elements among these organisms, the gut represents a highly active environment for resistance gene transfer.
Exposure to antimicrobials can potentially trigger extensive exchanges of mobile elements and resistance determinants among bacterial populations.
An important unanswered question is the extent to which resistance genes originating in anaerobic bacteria may transfer into aerobic pathogens of clinical significance.
Understanding these interactions will be critical for future antimicrobial stewardship efforts and for predicting how resistance may continue to evolve across microbial communities.
Key Takeaways
- Antibiotic resistance among anaerobic bacteria continues to increase across multiple antimicrobial classes.
- Horizontal gene transfer is a major driver of resistance dissemination within anaerobic microbial communities.
- Conjugative transposons such as CTnDOT facilitate the spread of resistance genes between bacteria.
- Metronidazole and carbapenem resistance, although still relatively uncommon, are clinically significant emerging concerns.
- Mobile genetic elements can transfer multiple resistance determinants simultaneously, promoting multidrug resistance.
- Advanced identification and genomic technologies are improving understanding of anaerobic resistance mechanisms and epidemiology.
Watch the Webinar On-Demand
For a more detailed exploration of antibiotic resistance mechanisms in anaerobic bacteria, including the genetic pathways responsible for resistance dissemination and their clinical significance, watch the full presentation by Dr Alida C.M. Veloo.
At Don Whitley Scientific, we are committed to supporting the microbiology community through educational resources that help laboratories stay informed about developments in anaerobic microbiology, antimicrobial resistance and emerging research.
England